ImaginAb

Happy Thanksgiving from ImaginAb! This Thanksgiving, we are grateful for our incredible team, partners, and the amazing advancements we’ve made together in the field of immuno-oncology. Wishing everyone a joyful and safe holiday filled with gratitude, warmth, and happiness. Thank you for being a part of our journey! #HappyThanksgiving #ImaginAb #Gratitude #Thankful #ImmunoOncology #Teamwork #TeamImaginAb?#Innovation #ImaginAb #CD8ImmunoPET #RPT #biotech #PETCT #research #clinicaltrials #Radiopharmaceuticals #RPT #Pharmaceuticals #theranostics

Our sales team is thrilled to announce that we will be attending this year’s American Society of Hematology's (ASH) 65th Annual Meeting in San Diego, CA! We are looking forward to engaging with fellow professionals, sharing our latest research, and exploring the newest advancements in hematology. It’s a fantastic opportunity to connect, learn, and contribute to the future of hematology. If you’re attending, we’d love to meet up and discuss how we can collaborate with you on your clinical trials. Schedule a meeting and meet us https://lnkd.in/gQmY2tFt #ASH2024 #Hematology #InnovationInMedicine #ImaginAb #CD8ImmunoPET #RPT #biotech #theranostics?#immunoonocology ?#research #clinicaltrials #Pharmaceuticals #NuclearMedicine #Innovation

Read our latest article: https://lnkd.in/gKgvJdvc Accurately assessing immune response in cancer patients undergoing immunotherapy is crucial for evaluating treatment efficacy and predicting outcomes. See how CD8+ T cells and the Immunoscore are two key biomarkers that are gaining attention in immunooncology. #ImmunoOncology #CancerTreatment #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy #oncology #medicalresearch

Our team enjoyed the Society for Immunotherapy of Cancer (SITC)'s Annual Meeting this year, and it was an unforgettable experience! From groundbreaking research presentations to inspiring keynote speeches, the event was a hub of innovation and collaboration in the field of cancer immunotherapy. Networking with fellow professionals and exchanging ideas with pioneers in the field was truly enriching. The discussions and insights gained will undoubtedly shape the future of our work and drive us closer to new breakthroughs in cancer treatment. A huge thank you to the organizers, speakers, and all the attendees who made this event so impactful. #SITC2024 #CancerImmunotherapy #MedicalInnovation #Networking #FutureOfMedicine #ImaginAb #CD8 #CD8ImmunoPET #RPT

Schedule a meeting by visiting: https://lnkd.in/gbqx5v9k Meet our Sales team at the Society for Immunotherapy of Cancer (SITC) Annual Meeting at booth #630 on November 8th & 9th. Learn how you can use CD8 Imaging in your clinical trials. Schedule a meeting today! #CD8ImmunoPET #immunooncology #pharma #biotech #SITC24?#radiopharmaceutical #PETCT #nuclearmedicine #theranostics #RPT

ImaginAb is proud to support Breast Cancer Awareness Month. We are committed to advancing the fight against breast cancer through our research and partnerships. Here is a look at two collaborative research studies that focus on metastatic breast cancer research: Evaluating the immunologically “cold” tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4+ and CD8+ T cells - https://lnkd.in/ghaiBSc9 Abstract PO1-20-12: CD8+ Tumor Infiltrating Lymphocytes Turn a Cold Tumor Hot in Metastatic Breast Cancer -https://lnkd.in/gEBVWMU8 Join us in raising awareness and supporting those affected by breast cancer. #ImaginAb #CD8ImmunoPET #RPT #biotech #theranostics?#immunoonocology ?#research #clinicaltrials #BreastCancerResearch #Pharmaceuticals #BreastCancerAwarenessDay

Read here: https://lnkd.in/g5gFrxJQ Dive into our latest article, "Pseudoprogression vs. True Progression in Immunotherapy: Challenges and Evaluation." Discover the complexities of distinguishing between pseudoprogression and true disease progression in the realm of immuno-oncology. Learn about the critical role of imaging techniques and the phenomenon of tumor flare. Don't miss out on this insightful read! Read here: https://lnkd.in/g5gFrxJQ #ImmunoOncology #CancerTreatment #Pseudoprogression #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy #oncology #medicalresearch

A huge thank you to the European Association of Nuclear Medicine (EANM) for organizing an incredible conference! The sessions were insightful, the networking opportunities were invaluable, and the overall experience was truly inspiring. We’re looking forward to next year’s meeting! #ImaginAb #CD8ImmunoPET #RPT #biotech #theranostics?#immunoonocology ?#research #clinicaltrials #Pharmaceuticals #EANM24 #EANM #EANM2024 #NuclearMedicine #Innovation

Schedule a meeting by visiting: https://lnkd.in/gbqx5v9k We are thrilled to announce that we will exhibit at this year’s Society for Immunotherapy of Cancer (SITC)’s 39th Annual Meeting! Our team is excited to connect with industry professionals and learn about the latest advancements in cancer research. Meet with Kristin Schmiedehausen, MD, Calmen Tihansky, Suzanne Bissonnette, Elizabeth Thomas and Clinique Burrell, MPA to get the latest updates on ImaginAb and CD8 ImmunoPET?. Visit us at booth #630 #CD8ImmunoPET #immunooncology #pharma #biotech #SITC24 ?#radiopharmaceutical #PETCT #nuclearmedicine #theranostics #RPT #ImaginAb

Check our latest Perspective’s blog by Matthew Hoover. Explore the transformative power of immuno-oncology therapies targeting CTLA-4, PD-1, and PD-L1, enhancing the immune system’s ability to fight tumors. While offering new hope, these treatments also present unique challenges, including immune-related adverse events (irAEs) that mirror autoimmune disorders and can impact any organ system. Early detection and management of irAEs are vital for patient outcomes. This blog delves into traditional and innovative methods for identifying irAEs, from clinical observation to advanced molecular imaging, ensuring optimized treatment and patient care. Read here: https://lnkd.in/gQgP4X99 #ImmunoOncology #CancerTreatment #irAEs #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy